1) Benotti JR, Grossman W, Braunwald E, et al. Hemodynamic assessment of amrinone--a new inotropic agent. N Engl J Med 1978; 299: 1373-1377.
2) LeJemtel TH, Keung E, Sonnenblick EH, et al. Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation 1979; 59: 1098-1104.
3) Jaski BE, Fifer MA, Wright RF, et al. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure: dose-response relationships and comparison to nitroprusside. J Clin Invest 1985; 75: 643-649.
4) Felker GM, Benza RL, Chandler AB, et al. Heart Failure Etiology and Response to Milrinone in Decompensated Heart Failure--Results From the OPTIME-CHF Study. J Am Coll Cardiol 2003; 41: 997-1003.
5) Gage J, Rutman H, Lucido D, et al. Additive effects of dobuta-mine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure. Circulation 1986; 74: 367-373.